الجمعة، 16 أغسطس 2024

🌎 Microchip Technology Upgraded, JD.com Upgraded, CAE Downgraded and more...

Ratings changes for Origin Materials, PayPal, Applied Materials, Reviva Pharmaceuticals, TTEC, Coherus BioSciences, JD.com and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
August 16th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • AFC Gamma (NASDAQ:AFCG) was upgraded by analysts at Compass Point from a "sell" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $10.00. This represents a 9.3% downside from the current price of $9.92.
  • Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $370.00 price target on the stock, up previously from $198.00. This represents a 38.5% upside from the current price of $267.24.
  • CF Industries (NYSE:CF) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $90.00 price target on the stock, up previously from $80.00. This represents a 11.6% upside from the current price of $80.61.
  • Cisco Systems (NASDAQ:CSCO) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock, up previously from $46.00. This represents a 16.9% upside from the current price of $49.60.
  • EnLink Midstream (NYSE:ENLC) was upgraded by analysts at Tudor, Pickering, Holt & Co. from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. This represents a 12.4% upside from the current price of $13.34.
  • FOX (NASDAQ:FOXA) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "overweight" rating. They now have a $46.00 price target on the stock, up previously from $29.00. This represents a 16.2% upside from the current price of $39.58.
  • Illumina (NASDAQ:ILMN) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to a "buy" rating. They now have a $154.00 price target on the stock, up previously from $120.00. This represents a 18.6% upside from the current price of $129.90.
  • JD.com (NASDAQ:JD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $36.00 price target on the stock, up previously from $33.00. This represents a 26.7% upside from the current price of $28.42.
  • Kimco Realty (NYSE:KIM) was upgraded by analysts at Raymond James from a "market perform" rating to a "strong-buy" rating. They now have a $25.00 price target on the stock. This represents a 12.4% upside from the current price of $22.24.
  • Kite Realty Group Trust (NYSE:KRG) was upgraded by analysts at Raymond James from a "market perform" rating to a "strong-buy" rating. They now have a $28.00 price target on the stock. This represents a 12.4% upside from the current price of $24.92.
  • Microchip Technology (NASDAQ:MCHP) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00. This represents a 23.9% upside from the current price of $80.74.
  • NIKE (NYSE:NKE) was upgraded by analysts at Williams Trading from a "sell" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $67.00. This represents a 11.0% upside from the current price of $83.75.
  • Newmark Group (NASDAQ:NMRK) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $15.00 price target on the stock. This represents a 17.4% upside from the current price of $12.78.
  • Origin Materials (NASDAQ:ORGN) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $3.00 price target on the stock, up previously from $1.35. This represents a 128.1% upside from the current price of $1.32.
  • Sphere Entertainment (NYSE:SPHR) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $57.00 price target on the stock, up previously from $37.00. This represents a 16.4% upside from the current price of $48.95.
  • Teradyne (NASDAQ:TER) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock. This represents a 87.8% downside from the current price of $131.59.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Bumble (NASDAQ:BMBL) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $7.50 price target on the stock, down previously from $22.00. This represents a 25.4% upside from the current price of $5.98.
  • CAE (NYSE:CAE) (TSE:CAE) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.The current price is $17.39.
  • Cardlytics (NASDAQ:CDLX) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $5.00 price target on the stock, down previously from $7.00. This represents a 38.1% upside from the current price of $3.62.
  • Coherus BioSciences (NASDAQ:CHRS) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $1.50 price target on the stock, down previously from $4.00. This represents a 12.4% upside from the current price of $1.34.
  • Estée Lauder Companies (NYSE:EL) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $100.00 price target on the stock, down previously from $140.00. This represents a 5.3% upside from the current price of $94.97.
  • Lumen Technologies (NYSE:LUMN) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $4.00 price target on the stock, up previously from $1.75. This represents a 29.8% downside from the current price of $5.70.
  • Silicon Motion Technology (NASDAQ:SIMO) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $60.00 price target on the stock, down previously from $90.00. This represents a 5.0% downside from the current price of $63.18.
  • Viracta Therapeutics (NASDAQ:VIRX) was downgraded by analysts at SVB Leerink LLC from an "outperform" rating to a "market perform" rating. They now have a $3.00 price target on the stock, down previously from $5.00. This represents a 889.4% upside from the current price of $0.30.
  • Vital Energy (NYSE:VTLE) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $36.41.
  • XOS (NASDAQ:XOS) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $17.00. This represents a 67.9% upside from the current price of $5.36.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Couchbase (NASDAQ:BASE) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $22.00 price target on the stock. This represents a 21.8% upside from the current price of $18.06.
  • Couchbase (NASDAQ:BASE) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $22.00 price target on the stock. This represents a 21.8% upside from the current price of $18.06.
  • Liquidia (NASDAQ:LQDA) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 91.5% upside from the current price of $14.10.
  • Two Harbors Investment (NYSE:TWO) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $15.00 price target on the stock. This represents a 9.6% upside from the current price of $13.69.
  • Y-mAbs Therapeutics (NASDAQ:YMAB) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $20.00 price target on the stock. This represents a 61.9% upside from the current price of $12.35.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Most powerful human in history says this technology is the solution

ليست هناك تعليقات:

إرسال تعليق

These Two Juicy Yields Won’t Last Long

If you're ditching money markets, read this…   November 21, 2024 These Two Juicy Yields Won’t Last Long ...